Neuropsychiatry and genomics

The Neuropsychiatry and genomics working group aim to investigate the range of psychiatric disorders resulting from COVID-19 and their potential mechanisms. Working with experts from across the UK from the full spectrum of relevant clinical and academic neurosciences we hope to answer these key questions to better understand and treat these important complications of COVID-19.



Back to: COVID-19 Clinical Neuroscience Study (COVID-CNS)